Intercept Pharmaceuticals Inc. (ICPT)

84.42
0.70 0.82
NASDAQ : Health Technology
Prev Close 85.12
Open 85.43
Day Low/High 83.29 / 85.47
52 Wk Low/High 51.05 / 135.59
Volume 233.12K
Avg Volume 682.10K
Exchange NASDAQ
Shares Outstanding 25.33M
Market Cap 2.15B
EPS -14.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of ICPT May 18th Options Trading

First Week of ICPT May 18th Options Trading

Investors in Intercept Pharmaceuticals Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Intercept Announces Multiple New Ocaliva® (obeticholic Acid) Data Presentations At The International Liver Congress™ 2018

Intercept Announces Multiple New Ocaliva® (obeticholic Acid) Data Presentations At The International Liver Congress™ 2018

Late-breaking presentation will feature the first clinical data from a biopsy-based substudy supporting obeticholic acid's ability to reverse or stabilize fibrosis and cirrhosis in primary biliary cholangitis (PBC) patients

Notable Friday Option Activity: ICPT, AGN, AXTA

Notable Friday Option Activity: ICPT, AGN, AXTA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intercept Pharmaceuticals Inc , where a total of 3,599 contracts have traded so far, representing approximately 359,900 underlying shares. That amounts to about 46.6% of ICPT's average daily trading volume over the past month of 772,405 shares.

First Week of February 2018 Options Trading For Intercept Pharmaceuticals (ICPT)

First Week of February 2018 Options Trading For Intercept Pharmaceuticals (ICPT)

Investors in Intercept Pharmaceuticals Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Noteworthy Wednesday Option Activity: ICPT, GOGO, RH

Noteworthy Wednesday Option Activity: ICPT, GOGO, RH

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intercept Pharmaceuticals Inc , where a total of 4,339 contracts have traded so far, representing approximately 433,900 underlying shares. That amounts to about 71.4% of ICPT's average daily trading volume over the past month of 608,115 shares.

Investors Shun Biotech Stocks

Investors Shun Biotech Stocks

The speed at which investors have bailed on this sector is alarming.

INTERCEPT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Intercept Pharmaceuticals, Inc. To Contact The Firm

INTERCEPT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Intercept Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Intercept Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Intercept Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - ICPT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Intercept Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - ICPT

Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc.

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Intercept Pharmaceuticals, Inc. Shareholders And A Lead Plaintiff Deadline Of November 27, 2017

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Intercept Pharmaceuticals, Inc. Shareholders And A Lead Plaintiff Deadline Of November 27, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

ICPT INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Intercept Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 27, 2017

ICPT INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Intercept Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 27, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Intercept...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Intercept Pharmaceuticals, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 27, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Intercept Pharmaceuticals, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 27, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Intercept Pharmaceuticals, Inc.

The Klein Law Firm Announces A Class Action Filed On Behalf Of Intercept Pharmaceuticals, Inc. Shareholders And A Lead Plaintiff Deadline Of November 27, 2017

The Klein Law Firm Announces A Class Action Filed On Behalf Of Intercept Pharmaceuticals, Inc. Shareholders And A Lead Plaintiff Deadline Of November 27, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc.

ICPT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Intercept Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 27, 2017

ICPT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Intercept Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 27, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Intercept...

First Week of June 2018 Options Trading For Intercept Pharmaceuticals (ICPT)

First Week of June 2018 Options Trading For Intercept Pharmaceuticals (ICPT)

Investors in Intercept Pharmaceuticals Inc saw new options become available this week, for the June 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D- (Sell)